With Erez Israeli set to step up from COO to CEO, Dr Reddy’s is looking to leverage its lack of debt and strong cash flow in the mergers and acquisitions arena.
Dr Reddy’s Laboratories will be looking to put its healthy balance sheet to work as it begins a new chapter under Erez Israeli as CEO from 1 August. Israeli, who joined the Indian company as chief operating officer just over a year ago, will report to GV Prasad, who has assumed the position of co-chairman and managing director.
“Since joining Dr Reddy’s as chief operating officer in April 2018,” the company commented, “Erez has spearheaded the transformational agenda...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
